Skip to main navigation Skip to search Skip to main content

Diagnostic utility of immunofixation and free light chain assay in AL amyloidosis: a systematic review and meta-analysis

  • Muayad Azzam
  • , Qais Hamarsha
  • , Hassan Kawtharany
  • , Jamil Nazzal
  • , Aseel Alkhader
  • , Tala Khraise
  • , Mohammad Mahmoud AlMasri
  • , Hadi Khaled Abou Zeid
  • , Iktimal Alwan
  • , Nour Jaber
  • , Matthew D. Seftel
  • , Maria Adela Aguirre
  • , Deborah Boedicker
  • , Naresh Bumma
  • , Antonia Carroll
  • , Raymond Comenzo
  • , Joselle Cook
  • , Noel Dasgupta
  • , Alfredo H. De La Torre
  • , Angela Dispenzieri
  • Faizi Jamal, Jack Khouri, Maria M. Picken, Shahzad Raza, Nelson Leung, Vaishali Sanchorawala, Nitasha Sarswat, Hira Shaikh, Daulath Singh, Vishal Kukreti, Reem A. Mustafa

Research output: Contribution to journal › Review article › peer-review

Abstract

In this systematic review, we aimed to assess the sensitivity of serum immunofixation (SIFE), urine immunofixation (UIFE), and serum free light chain (sFLC) in detecting plasma cell dyscrasia associated with light chain (AL) amyloidosis. We searched the literature using PubMed, Embase, and CENTRAL databases since inception through March 2024. We included studies reporting the diagnostic accuracy of immunofixation and/or sFLC in patients with AL amyloidosis. We used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach to assess the certainty of the evidence and QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies-2) to assess the risk of bias. After deduplication, 29 237 records were screened, and 44 studies (n = 18 071) were included. For the meta-analysis, 28 studies reported sensitivity for SIFE (n = 3390), 24 studies for UIFE (n = 2830), 19 studies for SIFE and UIFE (n = 2819), 21 studies for sFLC ratio (n = 3678), 6 studies for SIFE and sFLC ratio (n = 372), 3 studies for UIFE and sFLC ratio (n = 242), and 10 studies for all 3 tests (n = 1430). Pooled sensitivities were as follows: SIFE, 0.68 (95% confidence interval [CI], 0.62-0.73); UIFE, 0.77 (95% CI, 0.72-0.81); SIFE and UIFE, 0.89 (95% CI, 0.84-0.93); and sFLC ratio, 0.82 (95% CI, 0.78-0.86). When SIFE, UIFE, and sFLC ratio were combined, the sensitivity reached 0.99 (95% CI, 0.96-1.00). The high sensitivity of combining SIFE, UIFE, and sFLC ratio supports their use as a reliable initial testing strategy to raise suspicion for AL amyloidosis and guide decisions regarding future diagnostic modalities.

Original languageEnglish (US)
Pages (from-to)5293-5307
Number of pages15
JournalBlood Advances
Volume10
Issue number15
DOIs
StatePublished - Aug 11 2026

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Diagnostic utility of immunofixation and free light chain assay in AL amyloidosis: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this